Russian Ambassador to the US says Russia does not want a confrontation with the US, but the craft was too close to the Russian border

Post ContentRead More
Lawyers to Face Off Before Judge in Closely Watched Abortion Pills Case

The first hearing in a lawsuit that seeks to overturn F.D.A. approval of the pills takes place Wednesday morning in Texas.Read More
France’s Pension Plan Strikes, Explained

President Emmanuel Macron is forging ahead with plans to raise the legal age of retirement to 64, from 62, despite strikes, wide public opposition and a two-month showdown with labor unions.Read More
At Long Last, a Donkey Family Tree

In a new study, genetics and archaeology combine to reveal the ancient origins of humanity’s first beast of burden.Read More
How Siri, Alexa and Google Assistant Lost the A.I. Race

The virtual assistants had more than a decade to become indispensable. But they were hampered by clunky design and miscalculations, leaving room for chatbots to rise.Read More
Meet Tim Mayopoulos, the CEO of What Remains of Silicon Valley Bank

The F.D.I.C. named Tim Mayopoulos as chief executive of Silicon Valley Bridge Bank. His job is to keep calm and carry on.Read More
Stock Markets Tumble as Bank Fears Go Global

Shares fell sharply, with banking stocks taking a beating, as Tuesday’s rally quickly faded.Read More
How Washington Decided to Rescue Silicon Valley Bank

Officials were initially unsure about the need for the measures they eventually announced to shore up the financial system, but changed their minds quickly.Read More
Inside the Collapse of Silicon Valley Bank

While its leader extolled innovation and the future of tech, the bank paid less attention to risk management and was caught flat-footed by economic change.Read More
Aravive Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
HOUSTON, March 15, 2023 (GLOBE NEWSWIRE) — Aravive, Inc. (NASDAQ:ARAV, “the Company”)), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today reported fourth quarter and full year ended December 31, 2022 financial results and provided corporate updates. “As we reflect on a productive 2022, Aravive remains committed to driving progress across all […]